Literature DB >> 6751112

Efficacy of Fansidar against Plasmodium falciparum in continuous culture.

C R Brockelman, P Tan-Ariya.   

Abstract

Three recently isolated Thai strains of Plasmodium falciparum were tested in vitro for their response to pyrimethamine, sulfadoxine, and both compounds in combination. One isolate, FCK, was moderately tolerant to pyrimethamine whereas FCM3 and FCM5 were not affected by this compound at serum level, being 100 times less responsive than a sensitive strain from the Gambia when tested similarly. This low degree of response is evidently due to drug resistance. Sensitivity to sulfadoxine was low in the Thai isolates, but was also lower than expected in the Gambian strain. Possible causes of the poor response are discussed. Pyrimethamine in combination with sulfadoxine showed a synergistic effect; the effective doses were reduced by ten and three times, respectively.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6751112     DOI: 10.4269/ajtmh.1982.31.913

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  4 in total

1.  Plasmodium falciparum: mefloquine resistance produced in vitro.

Authors:  C Lambros; J D Notsch
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

2.  In vitro susceptibility of Plasmodium falciparum collected from pyrimethamine-sulfadoxine sensitive and resistant areas in Thailand.

Authors:  A Sabchareon; T Chongsuphajaisiddhi; P Attanath; K Kanjanapipatkul; E B Doberstyn; L Suebsaeng
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

3.  Thalassemic erythrocytes inhibit in vitro growth of Plasmodium falciparum.

Authors:  C R Brockelman; B Wongsattayanont; P Tan-ariya; S Fucharoen
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

4.  A nutrient mediates intraspecific competition between rodent malaria parasites in vivo.

Authors:  Nina Wale; Derek G Sim; Andrew F Read
Journal:  Proc Biol Sci       Date:  2017-07-26       Impact factor: 5.349

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.